Literature DB >> 25928582

Giardiasis surveillance -- United States, 2011-2012.

Julia E Painter, Julia W Gargano, Sarah A Collier, Jonathan S Yoder.   

Abstract

PROBLEM/CONDITION: Giardiasis is a nationally notifiable gastrointestinal illness caused by the protozoan parasite Giardia intestinalis. REPORTING PERIOD: 2011-2012. DESCRIPTION OF SYSTEM: Forty-four states, the District of Columbia, New York City, the Commonwealth of Puerto Rico, and Guam voluntarily reported cases of giardiasis to CDC through the National Notifiable Diseases Surveillance System (NNDSS).
RESULTS: For 2011, a total of 16,868 giardiasis cases (98.8% confirmed and 1.2% nonconfirmed) were reported; for 2012, a total of 15,223 cases (98.8% confirmed and 1.3% nonconfirmed) were reported. In 2011 and 2012, 1.5% and 1.3% of cases, respectively, were associated with a detected outbreak. The incidence rates of all reported cases were 6.4 per 100,000 population in 2011 and 5.8 per 100,000 population in 2012. This represents a slight decline from the relatively steady rates observed during 2005-2010 (range: 7.1-7.9 cases per 100,000 population). In both 2011 and 2012, cases were most frequently reported in children aged 1-4 years, followed by those aged 5-9 years and adults aged 45-49 years. Incidence of giardiasis was highest in Northwest states. Peak onset of illness occurred annually during early summer through early fall.
INTERPRETATION: For the first time since 2002, giardiasis rates appear to be decreasing. Possible reasons for the decrease in rates during 2011-2012 could include changes in transmission patterns, a recent change in surveillance case definition, increased uptake of strategies to reduce waterborne transmission, or a combination of these factors. Transmission of giardiasis occurs throughout the United States, with more frequent diagnosis or reporting occurring in northern states. Geographical differences might suggest actual regional differences in giardiasis transmission or variation in surveillance capacity across states. Six states did not report giardiasis cases in 2011-2012, representing the largest number of nonreporting states since giardiasis became nationally notifiable in 2002. Giardiasis is reported more frequently in young children, which might reflect increased contact with contaminated water or ill persons, or a lack of immunity. PUBLIC HEALTH ACTION: Educational efforts to decrease exposure to unsafe drinking and recreational water and prevent person-to-person transmission have the potential to reduce giardiasis transmission. The continual decrease in jurisdictions opting to report giardiasis cases could negatively impact the ability to interpret national surveillance data; thus, further investigation is needed to identify barriers to and facilitators of giardiasis case reporting. Existing state and local public health infrastructure supported through CDC (e.g., Epidemiology and Laboratory Capacity grants and CDC-sponsored Council of State and Territorial Epidemiologists Applied Epidemiology Fellows) could provide resources to enhance understanding of giardiasis epidemiology.

Entities:  

Mesh:

Year:  2015        PMID: 25928582

Source DB:  PubMed          Journal:  MMWR Suppl        ISSN: 2380-8942


  19 in total

Review 1.  Giardiasis outbreaks in the United States, 1971-2011.

Authors:  E A Adam; J S Yoder; L H Gould; M C Hlavsa; J W Gargano
Journal:  Epidemiol Infect       Date:  2016-01-11       Impact factor: 2.451

Review 2.  Small Intestinal Infections.

Authors:  Khushboo Munot; Donald P Kotler
Journal:  Curr Gastroenterol Rep       Date:  2016-06

Review 3.  Giardia: a pathogen or commensal for children in high-prevalence settings?

Authors:  Luther A Bartelt; James A Platts-Mills
Journal:  Curr Opin Infect Dis       Date:  2016-10       Impact factor: 4.915

4.  Genetic variation in potential Giardia vaccine candidates cyst wall protein 2 and α1-giardin.

Authors:  Matej Radunovic; Christian Klotz; Christina Skår Saghaug; Hans-Richard Brattbakk; Toni Aebischer; Nina Langeland; Kurt Hanevik
Journal:  Parasitol Res       Date:  2017-06-03       Impact factor: 2.289

5.  Click Chemistry-Facilitated Structural Diversification of Nitrothiazoles, Nitrofurans, and Nitropyrroles Enhances Antimicrobial Activity against Giardia lamblia.

Authors:  Wan Jung Kim; Keith A Korthals; Suhua Li; Christine Le; Jarosław Kalisiak; K Barry Sharpless; Valery V Fokin; Yukiko Miyamoto; Lars Eckmann
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

6.  Giardiasis Diagnosis and Treatment Practices Among Commercially Insured Persons in the United States.

Authors:  Karlyn D Beer; Sarah A Collier; Fan Du; Julia W Gargano
Journal:  Clin Infect Dis       Date:  2017-05-01       Impact factor: 9.079

7.  Assemblages A and B of Giardia duodenalis reduce enteric glial cells in the small intestine in mice.

Authors:  Mariana Felgueira Pavanelli; Cristiane Maria Colli; Renata Coltro Bezagio; Marcelo Biondaro Góis; Gessilda de Alcântara Nogueira de Melo; Eduardo José de Almeida Araújo; Débora de Mello Gonçales Sant'Ana
Journal:  Parasitol Res       Date:  2018-05-05       Impact factor: 2.289

8.  First genetic characterisation of Giardia in human isolates from Jordan.

Authors:  Nawal Hijjawi; Rongchang Yang; Rami Mukbel; Yasmeen Yassin; Taghrid Mharib; Una Ryan
Journal:  Parasitol Res       Date:  2016-05-20       Impact factor: 2.289

9.  Sphingolipids, Lipid Rafts, and Giardial Encystation: The Show Must Go On.

Authors:  Tavis L Mendez; Atasi De Chatterjee; Trevor Duarte; Joaquin De Leon; Leobarda Robles-Martinez; Siddhartha Das
Journal:  Curr Trop Med Rep       Date:  2015-09-01

10.  An audit of Cryptosporidium and Giardia detection in Scottish National Health Service Diagnostic Microbiology Laboratories.

Authors:  C L Alexander; S Currie; K Pollock; A Smith-Palmer; B L Jones
Journal:  Epidemiol Infect       Date:  2017-03-09       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.